230 related articles for article (PubMed ID: 27043030)
1. GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients.
Lukaszyk E; Lukaszyk M; Koc-Zorawska E; Bodzenta-Lukaszyk A; Malyszko J
Int Urol Nephrol; 2016 Jun; 48(6):839-44. PubMed ID: 27043030
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa.
Nalado AM; Olorunfemi G; Dix-Peek T; Dickens C; Khambule L; Snyman T; Paget G; Mahlangu J; Duarte R; George J; Naicker S
BMC Nephrol; 2020 Sep; 21(1):415. PubMed ID: 32993549
[TBL] [Abstract][Full Text] [Related]
3. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
Fertrin KY; Lanaro C; Franco-Penteado CF; de Albuquerque DM; de Mello MR; Pallis FR; Bezerra MA; Hatzlhofer BL; Olbina G; Saad ST; da Silva Araújo A; Westerman M; Costa FF
Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
[TBL] [Abstract][Full Text] [Related]
4. Association of hepcidin and anemia in early chronic kidney disease.
Sonkar SK; Singh NK; Sonkar GK; Pandey S; Bhosale V; Kumar A; Usman K
Saudi J Kidney Dis Transpl; 2019; 30(2):315-324. PubMed ID: 31031367
[TBL] [Abstract][Full Text] [Related]
5. Zonulin, inflammation and iron status in patients with early stages of chronic kidney disease.
Lukaszyk E; Lukaszyk M; Koc-Zorawska E; Bodzenta-Lukaszyk A; Malyszko J
Int Urol Nephrol; 2018 Jan; 50(1):121-125. PubMed ID: 29134616
[TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients.
Belo L; Rocha S; Valente MJ; Coimbra S; Catarino C; Bronze-da-Rocha E; Rocha-Pereira P; do Sameiro-Faria M; Oliveira JG; Madureira J; Fernandes JC; Miranda V; Santos-Silva A
Ren Fail; 2019 Nov; 41(1):662-672. PubMed ID: 31296086
[No Abstract] [Full Text] [Related]
8. Growth differentiation factor GDF-15 does not influence iron metabolism in stable chronic haemodialysis patients.
Li XY; Ying J; Li JH; Zhu SL; Li J; Pai P
Ann Clin Biochem; 2015 May; 52(Pt 3):399-403. PubMed ID: 25178559
[TBL] [Abstract][Full Text] [Related]
9. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
[TBL] [Abstract][Full Text] [Related]
11. The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease.
Mercadal L; Metzger M; Haymann JP; Thervet E; Boffa JJ; Flamant M; Vrtovsnik F; Houillier P; Froissart M; Stengel B;
PLoS One; 2014; 9(6):e99781. PubMed ID: 24978810
[TBL] [Abstract][Full Text] [Related]
12. Assessment of serum bioactive hepcidin-25, soluble transferrin receptor and their ratio in predialysis patients: Correlation with the response to intravenous ferric carboxymaltose.
Drakou A; Margeli A; Theodorakopoulou S; Agrogiannis I; Poziopoulos C; Papassotiriou I; Vlahakos DV
Blood Cells Mol Dis; 2016 Jul; 59():100-5. PubMed ID: 27282576
[TBL] [Abstract][Full Text] [Related]
13. Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease.
Tandara L; Grubisic TZ; Ivan G; Jurisic Z; Tandara M; Gugo K; Mladinov S; Salamunic I
Clin Biochem; 2015 Dec; 48(18):1252-7. PubMed ID: 26164540
[TBL] [Abstract][Full Text] [Related]
14. Iron Status and Inflammation in Early Stages of Chronic Kidney Disease.
Łukaszyk E; Łukaszyk M; Koc-Żórawska E; Tobolczyk J; Bodzenta-Łukaszyk A; Małyszko J
Kidney Blood Press Res; 2015; 40(4):366-73. PubMed ID: 26160488
[TBL] [Abstract][Full Text] [Related]
15. The Content of Reticulocyte Hemoglobin and Serum Concentration of the Soluble Transferrin Receptor for Diagnostics of Anemia in Chronically Hemodialyzed Patients.
Kurzawa T; Owczarek A; Strzelczyk JK; Gołąbek K; Wiczkowski A
Adv Clin Exp Med; 2016; 25(3):425-31. PubMed ID: 27629729
[TBL] [Abstract][Full Text] [Related]
16. Physiological Role of Serum Growth Differentiation Factor-15 (GDF-15) Level and Iron Metabolism in Community-Dwelling Older Adults.
Fukuda T; Yazawa H; Nishikawa R; Tokoi S; Kayashima R; Kono K; Sakuma M; Abe S; Toyoda S; Nakajima T
Cureus; 2024 May; 16(5):e60422. PubMed ID: 38883134
[TBL] [Abstract][Full Text] [Related]
17. Serum ferritin <70 μg/L predicts functional iron deficiency in patients with chronic kidney disease.
Garg N; Kotru M; Yadav A; Rusia U; Sikka M; Kalra OP
Saudi J Kidney Dis Transpl; 2018; 29(5):1035-1041. PubMed ID: 30381498
[TBL] [Abstract][Full Text] [Related]
18. Elevated Hepcidin Is Part of a Complex Relation That Links Mortality with Iron Homeostasis and Anemia in Men and Women with HIV Infection.
Minchella PA; Armitage AE; Darboe B; Jallow MW; Drakesmith H; Jaye A; Prentice AM; McDermid JM
J Nutr; 2015 Jun; 145(6):1194-201. PubMed ID: 25904736
[TBL] [Abstract][Full Text] [Related]
19. Maternal inflammation at delivery affects assessment of maternal iron status.
Lee S; Guillet R; Cooper EM; Westerman M; Orlando M; Pressman E; O'Brien KO
J Nutr; 2014 Oct; 144(10):1524-32. PubMed ID: 25080540
[TBL] [Abstract][Full Text] [Related]
20. GDF-15 and Hepcidin Levels in Nonanemic Patients with Impaired Glucose Tolerance.
Yalcin MM; Altinova AE; Akturk M; Gulbahar O; Arslan E; Ors Sendogan D; Yetkin I; Toruner FB
J Diabetes Res; 2016; 2016():1240843. PubMed ID: 27642607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]